These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Refractory neuro-Behçet treated by tocilizumab: a case report. Urbaniak P; Hasler P; Kretzschmar S Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S73-5. PubMed ID: 23020826 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of switching to adalimumab in a patient with refractory uveitis of Behçet's disease to infliximab. Leccese P; Latanza L; D'Angelo S; Padula A; Olivieri I Clin Exp Rheumatol; 2011; 29(4 Suppl 67):S93. PubMed ID: 21813069 [No Abstract] [Full Text] [Related]
4. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. Levy-Clarke G; Jabs DA; Read RW; Rosenbaum JT; Vitale A; Van Gelder RN Ophthalmology; 2014 Mar; 121(3):785-96.e3. PubMed ID: 24359625 [TBL] [Abstract][Full Text] [Related]
5. Infliximab therapy in parenchymal neuro-Behçet's disease: A single-center experience. Yalcin Kehribar D; Gunaydin S; Ozgen M Int J Rheum Dis; 2021 Oct; 24(10):1302-1307. PubMed ID: 34427044 [TBL] [Abstract][Full Text] [Related]
6. Late response to anti-TNF-α therapy in refractory mucocutaneous lesions of Behçet's disease. Aikawa NE; Gonçalves C; Silva CA; Gonçalves C; Bonfá E; de Carvalho JF Rheumatol Int; 2011 Aug; 31(8):1097-9. PubMed ID: 20012049 [TBL] [Abstract][Full Text] [Related]
7. Intestinal Behçet's disease: maintenance of remission with adalimumab monotherapy. Ariyachaipanich A; Berkelhammer C; Nicola H Inflamm Bowel Dis; 2009 Dec; 15(12):1769-71. PubMed ID: 19177427 [No Abstract] [Full Text] [Related]
8. Case of neuro-Behçet's disease successfully maintained a remission using infliximab for 2 years. Kanemaru H; Makino T; Jinnin M; Yonemitsu A; Makino K; Ihn H J Dermatol; 2013 Aug; 40(8):632-4. PubMed ID: 23724912 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of infliximab and adalimumab in the treatment of a patient with severe neuro-Behçet's disease. Belzunegui J; López L; Paniagua I; Intxausti JJ; Maíz O Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S133-4. PubMed ID: 19026138 [No Abstract] [Full Text] [Related]
10. Intestinal Behçet's disease appearing during treatment with adalimumab in a patient with ankylosing spondylitis. Chung SH; Park SJ; Hong SP; Cheon JH; Kim TI; Kim WH World J Gastroenterol; 2013 Aug; 19(32):5389-92. PubMed ID: 23983446 [TBL] [Abstract][Full Text] [Related]
11. Successful treatment of recalcitrant genital ulcers of Behçet's disease with adalimumab after failure of infliximab and etanercept. Olivieri I; D' Angelo S; Padula A; Leccese P; Mennillo GA Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S112. PubMed ID: 19796550 [No Abstract] [Full Text] [Related]
12. [Efficacy of TNF-alpha antagonist and other immunomodulators in the treatment of patients with ophthalmologic manifestations of Behcet's disease and HLA B51 positive vasculitis]. Zlatanović G; Jovanović S; Veselinović D; Zivković M Vojnosanit Pregl; 2012 Feb; 69(2):168-74. PubMed ID: 22500372 [TBL] [Abstract][Full Text] [Related]
13. Adalimumab for sight-threatening uveitis in Behçet's disease. Mushtaq B; Saeed T; Situnayake RD; Murray PI Eye (Lond); 2007 Jun; 21(6):824-5. PubMed ID: 16601736 [TBL] [Abstract][Full Text] [Related]
14. Successful treatment with adalimumab in a familial case of gastrointestinal Behcet's disease. De Cassan C; De Vroey B; Dussault C; Hachulla E; Buche S; Colombel JF J Crohns Colitis; 2011 Aug; 5(4):364-8. PubMed ID: 21683309 [TBL] [Abstract][Full Text] [Related]
15. Adalimumab treatment for life threatening pulmonary artery aneurysm in Behçet disease: a case report. Lee SW; Lee SY; Kim KN; Jung JK; Chung WT Clin Rheumatol; 2010 Jan; 29(1):91-3. PubMed ID: 19816754 [TBL] [Abstract][Full Text] [Related]
16. Neurological Sequelae in Youngest Adult Behcet's Disease Patient on Infliximab. Sultan M; Khan A; Habib SS; Hayat M J Coll Physicians Surg Pak; 2020 Jul; 30(7):762-764. PubMed ID: 32811612 [TBL] [Abstract][Full Text] [Related]
17. Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study. Interlandi E; Leccese P; Olivieri I; Latanza L Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S58-62. PubMed ID: 25005224 [TBL] [Abstract][Full Text] [Related]
18. Treatment of intestinal Behçet's syndrome with chimeric tumour necrosis factor alpha antibody. Travis SP; Czajkowski M; McGovern DP; Watson RG; Bell AL Gut; 2001 Nov; 49(5):725-8. PubMed ID: 11600479 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of Behçet's disease with adalimumab]. Callejas-Rubio JL; Sánchez-Cano D; Ríos-Férnandez R; Ortego-Centeno N Med Clin (Barc); 2008 Oct; 131(11):438-9. PubMed ID: 18928730 [No Abstract] [Full Text] [Related]
20. Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab. Leccese P; D'Angelo S; Angela P; Coniglio G; Olivieri I Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S102. PubMed ID: 20868587 [No Abstract] [Full Text] [Related] [Next] [New Search]